| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants L Ruggeri, M Capanni, E Urbani, K Perruccio, WD Shlomchik, A Tosti, ... Science 295 (5562), 2097-2100, 2002 | 3687 | 2002 |
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, ... The Lancet 371 (9624), 1579-1586, 2008 | 3019* | 2008 |
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy E Zappia, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, ... Blood 106 (5), 1755-1761, 2005 | 1757 | 2005 |
| Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia V Rocha, M Labopin, G Sanz, W Arcese, R Schwerdtfeger, A Bosi, ... New England Journal of Medicine 351 (22), 2276-2285, 2004 | 1185 | 2004 |
| Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation A Gratwohl, J Hermans, JM Goldman, W Arcese, E Carreras, A Devergie, ... The Lancet 352 (9134), 1087-1092, 1998 | 823 | 1998 |
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a … R Maccario, M Podestą, A Moretta, A Cometa, P Comoli, D Montagna, ... Haematologica 90 (4), 516-525, 2005 | 799 | 2005 |
| Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors S Giebel, F Locatelli, T Lamparelli, A Velardi, S Davies, G Frumento, ... Blood 102 (3), 814-819, 2003 | 663 | 2003 |
| Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis E Gerdoni, B Gallo, S Casazza, S Musio, I Bonanni, E Pedemonte, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 588 | 2007 |
| Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older … M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ... Leukemia 19 (12), 2304-2312, 2005 | 474 | 2005 |
| Mesenchymal stromal cells EM Horwitz, M Andreef, F Frassoni Current opinion in hematology 13 (6), 419, 2006 | 457 | 2006 |
| Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following … JWJ Van Esser, B Van Der Holt, E Meijer, HGM Niesters, R Trenschel, ... Blood, The Journal of the American Society of Hematology 98 (4), 972-978, 2001 | 392 | 2001 |
| Human mesenchymal stem cells promote survival of T cells in a quiescent state F Benvenuto, S Ferrari, E Gerdoni, F Gualandi, F Frassoni, V Pistoia, ... Stem cells 25 (7), 1753-1760, 2007 | 325 | 2007 |
| Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over … A Gratwohl, R Brand, F Frassoni, V Rocha, D Niederwieser, P Reusser, ... Bone marrow transplantation 36 (9), 757-769, 2005 | 304 | 2005 |
| Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells S Chiesa, S Morbelli, S Morando, M Massollo, C Marini, A Bertoni, ... Proceedings of the National Academy of Sciences 108 (42), 17384-17389, 2011 | 302 | 2011 |
| Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study F Frassoni, F Gualandi, M Podestą, AM Raiola, A Ibatici, G Piaggio, ... The lancet oncology 9 (9), 831-839, 2008 | 291 | 2008 |
| Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis P Ljungman, R Brand, H Einsele, F Frassoni, D Niederwieser, ... Blood 102 (13), 4255-4260, 2003 | 289 | 2003 |
| A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission … F Ciceri, M Labopin, F Aversa, JM Rowe, D Bunjes, P Lewalle, A Nagler, ... Blood, The Journal of the American Society of Hematology 112 (9), 3574-3581, 2008 | 287 | 2008 |
| Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia A Bacigalupo, MT Van Lint, D Occhini, F Gualandi, T Lamparelli, G Sogno, ... | 267 | 1991 |
| Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia G Barosi, G Viarengo, A Pecci, V Rosti, G Piaggio, M Marchetti, F Frassoni Blood, The Journal of the American Society of Hematology 98 (12), 3249-3255, 2001 | 254 | 2001 |
| The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group MS Freedman, A Bar-Or, HL Atkins, D Karussis, F Frassoni, H Lazarus, ... Multiple Sclerosis Journal 16 (4), 503-510, 2010 | 252 | 2010 |
